Berkeley Lights works to revolutionize how scientists study cells, in order to advance cellular therapies. By finding the best cells, the company aims to enable the rapid development of cell-based products, fundamentally changing the work of researchers.

The Berkeley Lights Platform provides innovative tools for identifying, measuring and manipulating cells, even enabling biologists to functionally screen and recover individual living cells. The platform delivers more information about cell function than any other technology currently available. This allows researchers to analyze deep phenotypic, functional and genotypic information, captured and translated into Digital Cell Biology, and also delivers the best cells for product development.

Founded in 2011, Berkeley Lights is currently focused on antibody therapeutics, cell therapy and synthetic biology, as well as biopharma, diagnostics and life science research. By increasing the probability of successful product development, their platforms and devices are becoming essential to the cell-based product value chain.

Meet the company